NVAX250110C6500
- 3.08
- +0.56+22.22%
Novavax Newsroom
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Novavax (NASDAQ:NVAX) Surges 35% This Week, Taking Five-year Gains to 171%
Novavax, Inc. (NVAX) Is Attracting Investor Attention: Here Is What You Should Know
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn Into More Strength?
Express News | Moderna and Novavax Surge Over 5% and 6% Respectively on CDC Report of Rising Respiratory Illness
Express News | Shares of U.S. Vaccine Maker Rise Premarket After Tuesday Surge
Express News | Moderna up 5.8%, Novavax up 7%
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. stock market close: Inflation concerns lead to a decline in all indexes, NVIDIA fell 6% after reaching a new high.
① The Nasdaq China Golden Dragon Index fell by 0.2%, with China Concept Stocks showing mixed results; ② NVIDIA launched its personal computing product Project DIGITS; ③ XPENG Huaitian: Flying cars will be mass-produced and delivered in 2026; ④ Vaccine stocks soared, with Moderna rising nearly 12% and Novavax increasing by nearly 11%.
Novavax Options Spot-On: On January 7th, 61,279 Contracts Were Traded, With 312.9K Open Interest
Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death -- Barrons.com
Why Novavax (NVAX) Stock Is Rising
Express News | Shares of Vaccine Makers Are Trading Higher After the First Bird Flu Death Was Reporting in the US. Additionally, a Recent DCD Report Noted an Increase in Acute Respiratory Illness Activity
Express News | Moderna up 7.5%, Novavax up 12.4%, Pfizer up 1.6%, U.S.-Listed Shares of CureVac up 10.6%
Express News | Shares of Vaccine Makers Rise in Early Trading
Possible Signal As Novavax Insiders Sell US$713k In Stock
CureVax and Novavax Rally as CDC Reports Rising U.S. COVID-19, RSV and Influenza Cases